Evaluation of cystatin C and β-2 microglobulin as markers of renal function in patients with type 2 diabetes mellitus

Journal of Diabetes and its Complications

Volumn 17, Issue 3, 2003, Pages 160-168

  Mojiminiyi, Olusegun A ^a   Abdella, Nabila ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Cystatin C; Diabetic nephropathy; Glomerular filtration rate; Type 2 diabetes mellitus; 2 microglobulin

Indexed keywords

BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; CREATININE; CYSTATIN C;

ADULT; AREA UNDER THE CURVE; ARTICLE; BETA 2 MICROGLOBULIN URINE LEVEL; CONTROLLED STUDY; CORRELATION FUNCTION; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL ANALYSIS;

EID: 0038639154     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(02)00177-0     Document Type: Article

References (41)

1. Standards of medical care for patients with diabetes mellitus (position statement). Diabetes Care. 21:1998;S23-S31.
2. 51Cr-EDTA clearance, creatinine clearance, serum β2 microglobulin and plasma creatinine. Journal of Clinical Pathology. 43:1990;370-372.
3. Ayatse J.O., Kwan J.T.C. Relative sensitivity of serum and urine retinol binding protein and alpha 1 microglobulin in the assessment of renal function. Annals of Clinical Biochemistry. 28:1991;514-516.
4. Barbosa J., Steffes M.W., Sutherland D.E., Connett J.E., Rao K.V., Mauer S.M. Effect of glycemic control on early diabetic renal lesions. JAMA, the Journal of the American Medical Association. 272:1994;600-606.
5. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1:1986;307-310.
6. Caramori M.L., Fioretto P., Mauer M. The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Diabetes. 49:2000;1399-1408.
7. Cockroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron. 16:1976;31-41.
8. Coresh J., Toto R.D., Kirk K.A., Whelton P.K., Massry S., Jones C., Agodoa L., Van Lente F. Creatinine clearance as a measure of GFR in screenees for the African-American Study of Kidney Disease and Hypertension pilot study. American Journal of Kidney Diseases. 32:1998;32-42.
9. DeFronzo R.A. Diabetic nephropathy: etiologic and therapeutic considerations. Diabetes Review. 3:1995;510-564.
10. Feldt-Rasmussen B., Mathiesen E.R., Deckert T. Effect of two years of strict metabolic control on progression of incipient diabetic nephropathy in insulin-dependent diabetics. Lancet. 2:1986;1300-1304.
11. Filler G., Witt I., Priem F., Ehrich J.H., Jung K. Are cystatin C and beta 2-microglobulin better markers than serum creatinine for prediction of a normal glomerular filtration rate in paediatric subjects? Clinical Chemistry. 43:1997;1077-1078.
12. Finney H., Newman D.J., Price C.P. Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Annals of Clinical Biochemistry. 37:2000;49-59.
13. Gault M.H., Fernandez D. Stable renal function in insulin-dependent diabetes mellitus 10 years after nephrotic range proteinuria. Nephron. 72:1996;86-92.
14. Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clinical Nephrology. 38:1992;S20-S27.
15. Grubb A., Simonsen O., Sturfelt G., Truedsson L., Thysell H. Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate. Acta Medica Scandinavica. 40:1985;499-503.
16. Harmoinen A.P., Kouri T.T., Wirta O.R., Lehtimaki T.J., Rantalaiho V., Turjanmaa V.M., Pasternack A.I. Evaluation of plasma cystatin C as a marker for glomerular filtration rate in patients with type 2 diabetes. Clinical Nephrology. 52:1999;363-370.
17. Hayashi T., Nitta K., Hatano M., Nakauchi M., Nihei H. The serum cystatin C concentration measured by particle-enhanced immunonephelometry is well correlated with inulin clearance in patients with various types of glomerulonephritis. Nephron. 82:1999;90-92.
18. Jung K., Schulze B.D., Sydow K., Pergande M., Precht K., Schreiber G. Diagnostic value of low-molecular mass proteins in serum for detection of reduced glomerular filtration rate. Journal of Clinical Chemistry and Biochemistry. 25:1987;499-503.
19. Kempermann F., Silberbusch J., Slaats E., van Zanten A., Weber J., Krediet R., Arisz L. Glomerular filtration rate estimation from plasma creatinine after inhibition of tubular secretion: relevance of the creatinine assay. Nephrology, Dialysis, Transplantation. 14:1999;1247-1251.
20. Krolewski A.S., Warram J.H. Natural history of diabetic nephropathy. Diabetes Review. 3:1995;446-459.
21. Kyhse-Andersen J., Schmidt C., Nordin G., Andersson B., Nilsson-Ehle P., LindstrÍom V. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clinical Chemistry. 40:1994;1921-1926.
22. Mathiesen E.R., Oxenboll B., Johansen K., Svendsen P.A., Deckert T. Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia. 26:1984;406-410.
23. Mogensen C.E. Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas. Diabetologia. 42:1999;263-285.
24. Mogensen C.E., Christensen C.K., Vittinghus E. The stages of diabetic renal disease with emphasis on the stage of incipient diabetic nephropathy. Diabetes. 32:1983;64-78.
25. Mogensen C.E., Keane W.F., Bennett P.H., Jerums G., Parving H.-H., Passa P., Steffes M.W., Striker G.E., Viberti G.C. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet. 346:1995;1080-1084.
26. Mojiminiyi A.O., Abdella N., George S. Evaluation of serum cystatin C and chromogranin A as markers of nephropathy in patients with type 2 diabetes mellitus. Scandinavian Journal of Clinical and Laboratory Investigation. 60:2000;483-489.
27. Mojiminiyi O.A., Al Shayji I., George S. Serum cystatin C could replace serum creatinine as an indicator of glomerular filtration rate in routine practice. European Journal of Laboratory Medicine. 6:1998;98-101.
28. Newman D.J., Thakkar H., Edwards R.G., Wilkie M., White T., Grubb A.O., Price C.P. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney International. 47:1995;312-318.
29. O'Bryan G.T., Hostetter T.H. The renal hemodynamic basis of diabetic nephropathy. Seminars in Nephrology. 17:1997;93-100.
30. Oddoze C., Morange S., Portugal H., Berland Y., Dussol B. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes. American Journal of Kidney Diseases. 38:2001;310-316.
31. Plebani M., Dall'Amico R., Mussap M., Montini G., Ruzzante N., Marsilio R., Giordano G., Zacchello G. Is serum cystatin C a sensitive marker of glomerular filtration rate (GFR)? A preliminary study on renal transplant patients. Renal Failure. 20:1998;303-309.
32. Randers E., Kristensen J.H., Erlandsen E.J., Danielsen H. Serum cystatin C as a marker of the renal function. Scandinavian Journal of Clinical and Laboratory Investigation. 58:1998;585-592.
33. Remaleya A.T., Sampson M.L., DeLeo J.M., Remaley N.A., Farsi B.D., Mark H., Zweig M.H. Prevalence-value-accuracy plots: a new method for comparing diagnostic tests based on misclassification costs. Clinical Chemistry. 45:1999;934-941.
34. Risch L., Blumberg A., Huber A. Rapid and accurate assessment of glomerular filtration rate in patients with renal transplants using serum cystatin C. Nephrology, Dialysis, Transplantation. 14:1999;1991-1996.
35. Sampson M.J., Drury P.L. Accurate estimation of glomerular filtration rate in diabetic nephropathy from age, body weight and serum creatinine. Diabetes Care. 15:1992;609-612.
36. Swan S.K. The search continues - an ideal marker of GFR. Clinical Chemistry. 43:1997;913-914.
37. Tian S., Kusano E., Ohara T., Tabei K., Itoh Y., Kawai T., Asano Y. Cystatin C measurement and its practical use in patients with various renal diseases. Clinical Nephrology. 48:1997;104-108.
38. Toto R.D. Conventional measurement of renal function utilizing serum creatinine, creatinine clearance, inulin and para-aminohippuric acid clearance. Current Opinion in Nephrology and Hypertension. 4(6):1995;505-509.
39. Toto R.D., Kirk K.A., Coresh J., Jones C., Appel L., Wright J., Campese V., Olutade B., Agodoa L. Evaluation of serum creatinine for estimating glomerular filtration rate in African Americans with hypertensive nephrosclerosis: results from the African-American Study of Kidney Disease and Hypertension (AASK) pilot study. Journal of the American Society of Nephrology. 8:1997;279-287.
40. Van Essen G.G., Stegeman C.A., Apperloo A.J., Rensma P.L., de Zeeuw D., de Jong P.E. Serum cystatin C is not superior to creatinine-based methods to estimate GFR during long term follow-up. Journal of the American Society of Nephrology. 8:1997;79A.
41. Zweig M.H., Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clinical Chemistry. 39:1993;561-577.